Short answer
AdaptHealth Corp. (AHCO) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 results covered quarter ended June 30, 2026.
AdaptHealth Corp. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 results covered quarter ended June 30, 2026
- Press release issued August 4, 2026 under Regulation FD
- Detailed financial results available in Exhibit 99.1
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $740.3M, up 12.7%, with organic growth of 15.9% across all reportable segments
- Adjusted EBITDA $132.0M, down 3.2%, with margin declining to 17.8% from 20.8%
- $144.2M goodwill impairment drove $145.3M attributable net loss versus $4.2M income
- Diabetes Health sale agreed at $235.0M cash, sharpening focus on Sleep, Respiratory, and Wellness-at-Home
- FY2026 guidance reduced to $2.85B–$2.89B revenue, $490M–$520M Adjusted EBITDA, and $80M–$120M free cash flow
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other AdaptHealth Corp. 8-K filings
Get the next AHCO 8-K as it lands
Follow AHCO for push alerts, or ask the research agent what this filing means.